Cargando…

Treating Primary Node-Positive Prostate Cancer: A Scoping Review of Available Treatment Options

SIMPLE SUMMARY: The best way to treat patients with prostate cancer who have positive lymph nodes is not clear. However, recent studies have suggested that intensifying treatment may help these patients and potentially cure their cancer. This review summarises the existing research that supports var...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zuur, Lotte G., de Barros, Hilda A., van der Mijn, Koen J. C., Vis, André N., Bergman, Andries M., Pos, Floris J., van Moorselaar, Jeroen A., van der Poel, Henk G., Vogel, Wouter V., van Leeuwen, Pim J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10251924/ https://www.ncbi.nlm.nih.gov/pubmed/37296924 http://dx.doi.org/10.3390/cancers15112962

Ejemplares similares

Sentinel Node Procedure to Select Clinically Localized Prostate Cancer Patients with Occult Nodal Metastases for Whole Pelvis Radiotherapy
por: de Barros, Hilda A., et al.
Publicado: (2023)

Abandon the Label of Clinically Insignificant Prostate Cancer
por: Mertens, Laura S., et al.
Publicado: (2022)

The oncological characteristics of non‐prostate‐specific membrane antigen (PSMA)‐expressing primary prostate cancer on preoperative PSMA positron emission tomography/computed tomography
por: Veerman, Hans, et al.
Publicado: (2022)

Current Routine Testosterone Immunoassays Are Unsuitable for Lowering the General Castration Cutoff Recommendation to <0.7 nmol/l (20 ng/dl)
por: van Rossum, Huub H., et al.
Publicado: (2023)

Identifying Patients in Whom the Follow-Up Scheme after Robot-Assisted Radical Prostatectomy Could Be Optimized in the First Year after Surgery: Reducing Healthcare Burden
por: Veerman, Hans, et al.
Publicado: (2023)

The clinical characteristics of patients with primary non‐prostate‐specific membrane antigen‐expressing prostate cancer on preoperative positron emission tomography/computed tomography
por: Veerman, Hans, et al.
Publicado: (2021)

PSMA-11-PET/CT versus choline-PET/CT to guide stereotactic ablative radiotherapy for androgen deprivation therapy deferral in patients with oligometastatic prostate cancer
por: Deijen, Charlotte L., et al.
Publicado: (2021)

Effects of furosemide and tracer selection on urinary activity and peri-bladder artefacts in PSMA PET/CT: a single-centre retrospective study
por: Donswijk, Maarten L., et al.
Publicado: (2022)

Enzalutamide therapy for advanced prostate cancer: efficacy, resistance and beyond
por: Linder, Simon, et al.
Publicado: (2018)

Use of gallium‐68 prostate‐specific membrane antigen positron‐emission tomography for detecting lymph node metastases in primary and recurrent prostate cancer and location of recurrence after radical prostatectomy: an overview of the current literature
por: Luiting, Henk B., et al.
Publicado: (2019)

Management impact of (18)F-DCFPyL PET/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study
por: Meijer, Dennie, et al.
Publicado: (2021)

External Validation of Two Nomograms Developed for (68)Ga-PSMA-11 Applied to the Prostate-specific Membrane Antigen Tracer (18)F-DCFPyl: Is Prediction of the Optimal Timing of Salvage Therapy Feasible?
por: Luiting, Henk B., et al.
Publicado: (2021)

Distribution of prostate cancer recurrences on gallium‐68 prostate‐specific membrane antigen ((68)Ga‐PSMA) positron‐emission/computed tomography after radical prostatectomy with pathological node‐positive extended lymph node dissection
por: Huits, Thijs H., et al.
Publicado: (2020)

Predicting early outcomes in patients with intermediate‐ and high‐risk prostate cancer using prostate‐specific membrane antigen positron emission tomography and magnetic resonance imaging
por: Meijer, Dennie, et al.
Publicado: (2021)

Diagnostic Performance of a Magnetic Resonance Imaging-directed Targeted plus Regional Biopsy Approach in Prostate Cancer Diagnosis: A Systematic Review and Meta-analysis
por: Hagens, Marinus J., et al.
Publicado: (2022)

Comment on Rosenzweig et al. Very Low Prostate PET/CT PSMA Uptake May Be Misleading in Staging Radical Prostatectomy Candidates. J. Pers. Med. 2022, 12, 410
por: Veerman, Hans, et al.
Publicado: (2022)

Selection of patients for nerve sparing surgery in robot‐assisted radical prostatectomy
por: Vis, André N., et al.
Publicado: (2021)

Higher Preoperative Maximum Standardised Uptake Values (SUV(max)) Are Associated with Higher Biochemical Recurrence Rates after Robot-Assisted Radical Prostatectomy for [(68)Ga]Ga-PSMA-11 and [(18)F]DCFPyL Positron Emission Tomography/Computed Tomography
por: de Bie, Katelijne C. C., et al.
Publicado: (2023)

State of the Art in Prostate-specific Membrane Antigen–targeted Surgery—A Systematic Review
por: Berrens, Anne-Claire, et al.
Publicado: (2023)

Quantitative 3T multiparametric MRI of benign and malignant prostatic tissue in patients with and without local recurrent prostate cancer after external‐beam radiation therapy
por: Dinis Fernandes, Catarina, et al.
Publicado: (2018)

The Implementation of FDG PET/CT for Staging Bladder Cancer: Changes in the Detection and Characteristics of Occult Nodal Metastases at Upfront Radical Cystectomy?
por: Einerhand, Sarah M. H., et al.
Publicado: (2023)

Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features
por: Dinis Fernandes, Catarina, et al.
Publicado: (2018)

Active inflammation in (18)F-methylcholine PET/CT
por: Le, Chau, et al.
Publicado: (2009)

Quantitative 3-T multi-parametric MRI and step-section pathology of recurrent prostate cancer patients after radiation therapy
por: Dinis Fernandes, Catarina, et al.
Publicado: (2018)

Specialist versus Primary Care Prostate Cancer Follow-Up: A Process Evaluation of a Randomized Controlled Trial
por: Wollersheim, Barbara M., et al.
Publicado: (2022)

Robot-assisted laparoscopic surgery using DROP-IN radioguidance: first-in-human translation
por: Meershoek, Philippa, et al.
Publicado: (2018)

Clinical impact of PSMA PET/CT in primary prostate cancer compared to conventional nodal and distant staging: a retrospective single center study
por: Donswijk, Maarten L., et al.
Publicado: (2020)

Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancer
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2015)

Verrast
por: van der Poel, Henk G.
Publicado: (2020)

Attention Does Not Affect the Speed of Subjective Time, but Whether Temporal Information Guides Performance: A Large‐Scale Study of Intrinsically Motivated Timers in a Real‐Time Strategy Game
por: van der Mijn, Robbert, et al.
Publicado: (2021)

Androgen receptor profiling predicts prostate cancer outcome
por: Stelloo, Suzan, et al.
Publicado: (2015)

Prostate-specific Membrane Antigen Positron Emission Tomography, Not Conventional Imaging, Should Be Performed for Primary Staging of High-risk Prostate Cancer: Con
por: van der Poel, Henk
Publicado: (2021)

Click-on fluorescence detectors: using robotic surgical instruments to characterize molecular tissue aspects
por: van Oosterom, Matthias N., et al.
Publicado: (2022)

Three-way multiplexing in prostate cancer patients — combining a bimodal sentinel node tracer with multicolor fluorescence imaging
por: Berrens, Anne-Claire, et al.
Publicado: (2022)

Endovascular embolization of posttraumatic high-flow priapism: Uncommon arteriovenous fistula of the corpus cavernosum
por: Otten, Maarten J., et al.
Publicado: (2022)

M1a prostate cancer: Results of a Dutch multidisciplinary consensus meeting
por: Aluwini, Shafak, et al.
Publicado: (2021)

The Effects of Enzalutamide Monotherapy on Multiparametric 3T MR Imaging in Prostate Cancer
por: Van der Roest, Rosanne CV., et al.
Publicado: (2016)

Prostate MRI for Improving Personalized Risk Prediction of Incontinence and Surgical Planning: The Role of Membranous Urethral Length Measurements and the Use of 3D Models
por: Boellaard, Thierry N., et al.
Publicado: (2023)

Challenges and future options for the production of lutetium-177
por: Vogel, W. V., et al.
Publicado: (2021)

Selection of Protein Kinase Inhibitors Based on Tumor Tissue Kinase Activity Profiles in Patients with Refractory Solid Malignancies: An Interventional Molecular Profiling Study
por: Labots, Mariette, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gbcgh8lehrl22u7sb5eodj70c1